Journal of Inherited Metabolic Disease · 1999 · 145 citations · 17 references
MedicineHematologySurgeryCell TherapyPediatric HematologyStem Cell TransplantationBone Marrow PathologyEngraftment MonitoringTransplant Outcomes
We describe the results of bone marrow transplantation (BMT) in four patients with mucopolysaccharidosis type VI (MPS VI, McKusick 253200)--Maroteaux-Lamy disease. The indications for transplantation were cardiomyopathy in three patients and severe obstructive sleep apnoea in one. The follow-up period ranges between 1 and 9 years, and three of the patients are at mainstream schools. In all of the patients the facial features have become less coarse and the cardiac manifestations have improved or remained stable. However, skeletal changes have persisted or even progressed, although posture and joint mobility have improved and all the patients have remained ambulatory and active. BMT appears to prolong survival and improve the quality of life in MPS VI patients, but careful selection of patients is essential.
17
Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome
Charles Peters, M. Balthazor, Craig Kollman et al. · Blood · 1996 · 318 citations · Full text
Medicine, Hematology, Pediatrics +14
Allogeneic bone marrow transplantation for lysosomal storage diseases
Peter M. Hoogerbrugge, Oebele F. Brouwer, Pierre Bordigoni et al. · The Lancet · 1995 · 260 citations · Full text